- Home
- General Medicine
- MedX Weekly: Lenacapavir Approved as 6-Month Injectable PrEP, Garadacimab for HAE, Enlicitide in Hyperlipidemia & More

5d3 min read
Medical Article
Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Approves First Long-Acting Injectable PrEP with 6-Month Protection The FDA has approved the first twice-yearly injectable HIV-1 capsid inhibitor for pre-exposure prophylaxis in adults and adolescents weighing at least 35 kg. This long
MedX Weekly: Lenacapavir Approved as 6-Month Injectable PrEP, Garadacimab for HAE, Enlicitide in Hyperlipidemia & More
Similar Content

Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments

Complicated case of Osteoarthritis
1849 Reached2 Comments3 Likes

Case of Pulmonary Embolism with Syncope
544 Reached4 Likes

Safe Ramadan Practices during COVID-19 - WHO Guidance
4873 Reached8 Comments3 Likes

Vildagliptin in Reducing Risk of Post-partum Diabetes
2383 Reached7 Comments4 Likes